Related Experiment Videos
Frontiers of Ovarian Cancer Therapy
1University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Cancer Control : Journal of the Moffitt Cancer Center
|March 1, 1996
Summary
Advanced ovarian cancer requires better systemic treatments beyond surgery. Promising future therapies include chemotherapy combinations, immunotherapy, hormone therapy, and gene therapy to improve patient survival.
Area of Science:
- Oncology
- Gynecologic Oncology
- Cancer Therapeutics
Background:
- Most ovarian cancer patients are diagnosed at advanced stages, necessitating systemic treatments alongside surgery.
- Current standard treatments involve surgical staging and debulking, but improved systemic options are crucial.
Purpose of the Study:
- To review current and emerging systemic therapeutic strategies for advanced ovarian cancer.
- To highlight the potential of novel treatment modalities in improving patient outcomes.
Main Methods:
- Literature review of systemic therapies for ovarian cancer.
- Analysis of chemotherapy combinations, immunotherapy, hormone therapy, and gene therapy approaches.
Main Results:
- Combinations of taxoids and cisplatin have shown survival benefits.
- Various chemotherapeutic agents are under evaluation for efficacy.
- Immunotherapy (monoclonal antibodies, cellular therapies, vaccines), hormone therapy (tamoxifen), and gene therapy show future promise.
Conclusions:
- Effective systemic therapies are essential for advanced ovarian cancer.
- Future treatment paradigms may involve diverse approaches including immunotherapy and gene therapy.